Enhanced SET expression has been observed in many human tumors including breast cancer, chronic myeloid leukemia, and B-cell non-Hodgkin lymphoma, and SET expression levels have moreover been shown to correlate positively with poor prognosis of chronic myeloid leukemia15, 16. Here, SET is linked to chronic myelogenous leukemia, BCR-ABL1 positive.